
A breakdown of side effects, user errors, and when to actually worry.
Most people who quit peptides in the first two weeks quit for the wrong reason.
Not because the peptide wasn't working. Not because they sourced wrong. But because something felt off and nobody told them that was completely normal.
A little puffiness. Some tingling. A headache on day three. So they panicked, stopped, and never found out what was waiting on the other side of that adjustment window.
Here is what you actually need to know.
GH Peptides (CJC-1295, Ipamorelin, Sermorelin, Tesamorelin)
Water retention and puffiness. Growth hormone causes your body to hold onto water, especially in the first few weeks when GH output is running above your baseline. It levels off. Stay hydrated, ease up on sodium, and give it 2 to 4 weeks before drawing any conclusions.
Tingling or numbness in the hands. Elevated GH increases fluid around the nerves in your wrists. It feels like carpal tunnel and it is temporary. Spacing out your injections or lowering the dose usually handles it.
Increased hunger. GH stimulates appetite. That is part of how it works. With Ipamorelin especially, the hunger can catch you off guard if you are not prepared. Time your injection before a meal and use it to your advantage.
Headaches and fatigue. Almost always a timing or dose issue. Start low at 100 to 200mcg, inject before bed to align with your natural GH pulse, and drink more water. Most of this clears up within the first week.
Nausea. Most common with BPC-157 at higher doses or taken orally without food. Start at 250mcg and work up. Jumping straight to 500mcg your first week is how you end up feeling sick and quitting something that would have helped you.
Dizziness and injection site irritation. Both are dose-dependent and resolve quickly. Rotate your sites, let your BAC water reach room temperature before injecting, and slow down. Most injection site reactions are from poor technique, not the peptide.
Mood shifts and overstimulation. Semax is activating. It hits dopamine and BDNF, which is why some people feel sharper and edgier at the same time. If irritability or anxiety shows up, you are either starting too high or your nervous system needs a gentler on-ramp. Pair it with Selank or back off the dose.
Nasal irritation. Expected with intranasal delivery. Use a clean dropper, let each nostril clear between doses, and consider SubQ if it becomes a recurring problem.
When it is not the peptide's fault
Some "side effects" are just user error.
Stinging on injection usually means you are going too fast or the solution is cold. Fever or chills after injecting is a red flag pointing to contaminated BAC water or a compromised vial. Stop and reassess your source. Feeling nothing at all is almost always a dosing math error. Most beginners under-dose and never realize it.
The one rule worth remembering
Normal side effects are mild, temporary, and get better as your body adapts. Real red flags get worse over time, not better.
Give yourself two weeks at a lower dose before making any decisions. The people who get results from peptides are not the ones with perfect protocols on day one. They are the ones who understood enough not to quit during the adjustment window.
That kind of knowledge is exactly what we talk about inside The Peptide Community every day. Members post their protocols, ask questions, and get real answers from people who have actually been through this. If you want that support system around you, the door is open.
Now you do too.
Lee
P.S. If you want clean, third-party tested product from sources I personally trust, here are the ones I recommend: Limitless Life Nootropics, BioLongevity Labs, Peptira, and Paramount Peptides.
Peptide Community & Member Perks
Sources:
Sikiric P, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Current Pharmaceutical Design, 2011. https://pubmed.ncbi.nlm.nih.gov/21175434/
Ionescu M, Frohman LA. "Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog." Journal of Clinical Endocrinology and Metabolism, 2006. https://pubmed.ncbi.nlm.nih.gov/16234304/
Raun K, et al. "Ipamorelin, the first selective growth hormone secretagogue." European Journal of Endocrinology, 1998. https://pubmed.ncbi.nlm.nih.gov/9849822/
Moller N, Jorgensen JO. "Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects." Endocrine Reviews, 2009. https://pubmed.ncbi.nlm.nih.gov/19407252/
Vasireddi N, et al. "Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review." HSS Journal, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/
